Information for students, faculty and staff regarding COVID-19. (Updated: 26 February 2021)

Svenska
Umeå University
printicon
Staff photo Francesca Aguilo

Francesca Aguilo

Contact

E-mail
francesca.aguilo@umu.se

Works at

Affiliation
Assistant professor at Department of Molecular Biology
Location
6K och 6L, Sjukhusområdet Umeå universitet, 901 87 Umeå
Affiliation
Affiliated as other position at Wallenberg Centre for Molecular Medicine at Umeå University (WCMM)
Location
Umeå universitet, 901 87 Umeå
Steering pluripotency and differentiation with N6-methyladenosine RNA modification
Biochimica et Biophysica Acta. Gene Regulatory Mechanisms, Elsevier 2019, Vol. 1862, (3) : 394-402
Malla, Sandhya; Melguizo-Sanchis, Dario; Aguilo, Francesca
Long non-coding RNA and Polycomb: an intricate partnership in cancer biology
Frontiers in Bioscience, Vol. 23 : 2106-2132
Achour, Cyrinne; Aguilo, Francesca
The N6-Methyladenosine RNA modification in pluripotency and reprogramming
Current Opinion in Genetics and Development, Elsevier 2017, Vol. 46 : 77-82
Aguilo, Francesca; Walsh, Martin J.
THAP1: Role in Mouse Embryonic Stem Cell Survival and Differentiation
Stem Cell Reports, CELL PRESS 2017, Vol. 9, (1) : 92-107
Aguilo, Francesca; Zakirova, Zuchra; Nolan, Katie; et al.
The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer
Nucleic Acids Research, Oxford University Press 2017, Vol. 45, (19) : 11106-11120
Rengasamy, Madhumitha; Zhang, Fan; Vashisht, Ajay; et al.
Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease
Long non-coding RNAs in human disease, Springer 2016 : 29-39
Aguilo, Francesca; Di Cecilia, Serena; Walsh, Martin J
Deposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1α
Cell reports, Vol. 14, (3) : 479-492
Aguilo, Francesca; Li, SiDe; Balasubramaniyan, Natarajan; et al.
RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells
Cancer Research, Vol. 76, (19) : 5615-5627
Di Cecilia, Serena; Zhang, Fan; Sancho, Ana; et al.
ZNF217/ZFP217 Meets Chromatin and RNA
TIBS -Trends in Biochemical Sciences. Regular ed., Vol. 41, (12) : 986-988
Lee, Dung-Fang; Walsh, Martin J.; Aguiló, Francesca
Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7
ACS Medicinal Chemistry Letters, Vol. 7, (6) : 601-605
Ren, Chunyan; Smith, Steven G.; Yap, Kyoko; et al.
Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming.
Cell Stem Cell, Vol. 17, (6) : 689-704
Aguilo, Francesca; Zhang, Fan; Sancho, Ana; et al.
CHD6 regulates the topological arrangement of the CFTR locus
Human Molecular Genetics, Vol. 24, (10) : 2724-2732
Sancho, Ana; Li, SiDe; Paul, Thankam; et al.
Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation.
EMBO Journal, Vol. 32, (7)
Martin, Nadine; Popov, Nikolay; Aguilo, Francesca; et al.
Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling.
Cell Stem Cell, Vol. 11, (2)
Lee, Dung-Fang; Su, Jie; Ang, Yen-Sin; et al.
Prdm16 is a physiologic regulator of hematopoietic stem cells.
Blood, Vol. 117, (19)
Aguilo, Francesca; Avagyan, Serine; Labar, Amy; et al.
Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression.
Cancer Research, Vol. 71, (16)
Aguilo, Francesca; Zhou, Ming-Ming; Walsh, Martin J
Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis.
Blood, Vol. 118, (23)
Avagyan, Serine; Aguilo, Francesca; Kamezaki, Kenjiro; et al.
Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma.
Biochemical Journal, Vol. 427, (2)
Aguiló, Francesca; Camarero, Nuria; Relat, Joana; et al.
View publications in DiVA

Research groups

Head of research
Francesca Aguilo
Targeting cancer cells without affecting healthy cells
Targeting cancer cells without affecting healthy cells

Francesca Aguilos work lies at the cutting edge of biomedical research and cancer.